Takeda Pharmaceutical Co Ltd

* Co, Altos Therapeutics have entered into agreement tofurther development of Altos's proprietary compound ATC-1906

* Deal has option for co to acquire Altos from date ofagreement, continuing for some time after completion of Phase 1studies of ATC-1906

* As part of agreement, Takeda will provide Altos an upfrontpayment for option to acquire Altos

* If Takeda elects to exercise option to buy Altos, Takedawould make an additional payment to acquire Altos

* Altos would be eligible to receive additional paymentslinked to clinical development and achievement of key commercialmilestones

* No further details of agreement were disclosedSource text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)